Efficacy of Rociletinib (CO-1686) in Centrally Confirmed T790M-positive and T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients (Pts) Sequist, L. V., Goldman, J. W., Wakelee, H., Camidge, D. R., Gadgeel, S., Yu, H. A., Varga, A., Solomon, B., Oxnard, G. R., Ou, S. I., Papadimitrakopoulou, V., Liu, S. V., Reckamp, K. L., Spira, A. I., Despain, D., Karlovich, C. A., Yurasov, S., Soria, J. KARGER. 2016: 121

View details for Web of Science ID 000371353700392